Skip to main content

People in the News: Janet Davison Rowley, Brian Druker, Nicholas Lydon

Premium

Janet Davison Rowley, the Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics, and Cell Biology and Human Genetics at the University of Chicago; Brian Druker of the Oregon Health and Science University; and Nicholas Lydon, formerly with Novartis, are the recipients of the 2012 Japan Prize for Healthcare and Medical Technology. They were awarded the prize for their roles in the development of the targeted anti-cancer drug Gleevec.

The three researchers "have made significant contributions to society by achieving momentous scientific and technological breakthroughs in creating and promoting new technologies for medical diagnosis and treatment," the Japan Prize Foundation said in a statement this week. They will each receive an equal share of 50 million Japanese Yen (approximately $215,000).

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.